Trademark: 90452726
Status Date
Tuesday, August 23, 2022
Registration Number
6823692
Registration Date
Tuesday, August 23, 2022
Filing Date
Thursday, January 7, 2021
Published for Opposition
Tuesday, June 7, 2022
5 Cell therapy pharmaceutical preparations; immunotherapy preparations; T-cell receptors; immunotherapy preparations comprising engineered T-cell Cell therapy pharmaceutical preparations for use in cancer treatment; pharmaceutical immunotherapy preparations for use in cancer treatment; T-cell receptors, namely, pharmaceutical preparations for use in cancer treatment; pharmaceutical immunotherapy preparations comprising engineered T-cell receptors for use in cancer treatment; pharmaceutical immunotherapy preparations comprising genes encoding engineered T-cell receptors for use in cancer treatment
44 Cell therapy medical treatment services; Medical services, namely, immunotherapy services; Medical services, namely, medical treatment and immune-therapy comprising harvesting a patient's white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient
Aug 23, 2022
Notice Of Registration Confirmation Emailed
Aug 23, 2022
Registered-Principal Register
Jun 7, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 7, 2022
Published For Opposition
May 18, 2022
Notification Of Notice Of Publication E-Mailed
Apr 29, 2022
Electronic Record Review Complete
Mar 30, 2022
On Hold - Electronic Record Review Required
Mar 11, 2022
Approved For Pub - Principal Register
Feb 10, 2022
Teas/Email Correspondence Entered
Feb 10, 2022
Correspondence Received In Law Office
Feb 8, 2022
Assigned To Lie
Feb 8, 2022
Teas Response To Suspension Inquiry Received
Jul 19, 2021
Notification Of Letter Of Suspension E-Mailed
Jul 19, 2021
Letter Of Suspension E-Mailed
Jul 19, 2021
Suspension Letter Written
Jul 19, 2021
Examiner's Amendment Entered
Jul 19, 2021
Notification Of Examiners Amendment E-Mailed
Jul 19, 2021
Examiners Amendment E-Mailed
Jul 19, 2021
Examiners Amendment -Written
Jul 16, 2021
Assigned To Examiner
Apr 6, 2021
New Application Office Supplied Data Entered In Tram
Jan 11, 2021
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
